Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment by Jacobsen, Peter A. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2021-11-02 and may be subject to
change.
Jacobsen et al. Respir Res          (2021) 22:147  
https://doi.org/10.1186/s12931-021-01736-6
RESEARCH
Characteristics and treatable traits 
of patients with chronic obstructive pulmonary 
disease (COPD) with and without paid 
employment
Peter A. Jacobsen1,2* , Alex J. van ’t Hul3, Remco S. Djamin4, Jeanine C. Antons3, Marianne de Man5, 
Ulla Møller Weinreich1,2, Martijn A. Spruit6,7,8 and Daisy J. A. Janssen6,9 
Abstract 
Introduction: Patients with COPD are vulnerable to workforce detachment. Better knowledge of features associated 
with paid work loss might be of help to design and select appropriate interventions.
Method: This cross-sectional study aimed to explore the presence of treatable traits in COPD patients without paid 
work. Patients with COPD below 65 years at first referral to a hospital-based patient clinic were included. Using binary 
logistic regression analysis, the relationship between paid work and the following characteristics was explored: low 
daily physical activity, exercise, active smoking, Medical Research Council dyspnea scale (MRC), poor nutritional status, 
exacerbations, and fatigue (checklist individual strength (CIS)). Variables were adjusted for age, sex, forced expiratory 
volume in 1 s (FEV 1), and education level.
Results: In total, 191 patients (47.3%) were without paid work. The following treatable traits were related to not being 
in paid work: < 5000 steps/day (OR 2.36, 95% CI (1.52–3.68)), MRC ≥ 3 (OR 1.78, 95%CI (1.14–2.77)), CIS ≥ 36 points (OR 
1.78, 95% CI (1.10–2.87)), six-minute walk distance (6MWD) < 70% of predicted (OR 2.62, 95% CI (1.69–4.06)), and ≥ 2 
exacerbations per year (OR 1.80, 95% CI (1.12–2.92)). Significant differences were also seen in age (OR 1.06, 95% CI 
(1.02–1.10) per year), FEV 1% predicted (OR 0.98, 95% CI (0.97–1.00) per % predicted increase), and medium/high 
education level (OR 0.62, 95% CI (0.41–0.93)). When adjusting for all variables the only treatable trait that remained 
significant was 6MWD.
Conclusion: Patients without paid work are more likely to have treatable traits with 6MWD revealing the most signifi-
cant association.
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Introduction
As the third leading cause of death in the world, Chronic 
Obstructive Pulmonary Disease (COPD) impacts mil-
lions of lives every day [1]. It has been estimated that 
5–6% of adults in the Netherlands above the age of 40 
have COPD, which comes with, apart from the increased 
risk of death, large impairments in patients daily living 
and quality of life (QoL) [2, 3]. Two studies conducted 
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in European countries reported that approximately 60% 
of COPD patients below retirement age are outside the 
workforce [4, 5]. Unemployment in general is associ-
ated with an increased risk of all-cause mortality and 
for patients with COPD also with a lower health related 
quality of life (HRQoL) and poorer medical adherence 
[6–9]. The poor workforce connection comes with large 
public expenses in the form of increased public support 
expenses and decreased tax revenue [10, 11]. The benefits 
of maintaining the workforce connection are therefore 
both from a societal and an individual perspective highly 
important.
Different characteristics of patients outside the work-
force have been examined in COPD. Older age, female 
sex, poorer prognostic score (Body mass index (BMI), 
airflow Obstruction, Dyspnea, Exercise (BODE score)), 
more severe dyspnea (modified Medical Research Coun-
cil (mMRC)), increased airflow obstruction, lower educa-
tional level and work related exposure to vapors, gasses, 
dust or fumes have all been associated with a poorer 
workforce connection with some discrepancies in the 
literature regarding the relationship of airflow obstruc-
tion with workforce connection [5, 12–15]. In a review 
of work-related outcomes in patients with COPD, Rai 
et al. concluded that there is a need for studies examin-
ing modifiable aspects of the disease in order to improve 
interventions to increase workforce connection [13].
This study was therefore performed to examine dif-
ferences in modifiable characteristics (treatable traits) 
of COPD in patients with and without paid work. We 
hypothesize that certain treatable traits are more preva-




At the time of the study public retirement was available in 
the Netherlands for all people of 65 years and older. Dis-
ability retirement is available to patients below 65 years 
with either physical or mental impairments that impairs 
their ability to work.
Study design
This study is a secondary analysis of the COPD sTRAI-
Tosphere study and uses an observational cross-sectional 
cohort study design [16]. Data was collected upon refer-
ral from the general practitioner to a pulmonologist for 
a hospital-based outpatient consultation, through a com-
prehensive diagnostic examination. The Research Ethics 
Committee of the Radboud University Medical Centre, 
Netherlands, approved the study. Due to the observa-
tional nature of the study and the provision of usual care, 
written informed consent was waived (ref: 2017/3597).
Study population
Patients were included between April 2013 to Decem-
ber 2018. Included patients were the first time referred 
to a pulmonologist with a confirmed diagnosis of COPD 
and were free from exacerbations three months prior to 
inclusion. The diagnosis of COPD was confirmed using 
post-bronchodilator spirometry with a Tiffeneau-Penelli 
index < 70%. Data were collected from three centers in 
the Netherlands: Radboudumc, Nijmegen, Amphia hos-
pital, Breda, and Bernhoven hospital, Uden. Patients aged 
65 years and above were excluded as this was the mini-
mum retirement age in the Netherlands during the study 
period (Fig. 1). Patients with incomplete data on educa-
tion and work were also excluded.
Outcomes and covariates
Patients reported at baseline examination if they were 
currently employed in paid work (“Yes” or “No”). Patients 
categorized as “No paid work” may therefore be unem-
ployed or receive disability retirement.
The following other data were collected: Age, sex, 
comorbidities, educational level, spirometry (performed 
on Masterlab PFT; Vitalaire, Germany, spirometer, using 
post-bronchodilator (after inhalation of salbutamol 
400 μg) spirometry estimated using the Global Lung Ini-
tiative equation), blood gas analysis, body mass index 
(BMI), six-minute walk test (6MWD), steps per day 
(recorded with activity monitor (Yamex or Dynaport)), 
exacerbation history during the last year (patients’ recall), 
checklist individual strength ((CIS), fatigue assessment), 
medical research council (MRC) score, clinical COPD 
questionnaire (CCQ) and smoking status. Education level 
was grouped into short (finished low-level secondary 
Fig. 1 Flow chart of included patients. Abbreviations: Chronic 
obstructive pulmonary disease (COPD), forced expiratory volume in 
one second  (FEV1), forced vital capacity (FVC)
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education or lower (International Standard Classification 
of Education(ISCED) level 0–2)), and medium/high (fin-
ished upper secondary education or above (ISCED 3–8)) 
[17].
The selection of treatable traits was chosen through 
the availability of evidence-based interventions, as done 
by van ‘t Hul et  al. [16]. Treatable traits include smok-
ing (currently smoking), activity-related dyspnea (MRC 
grade ≥ 3), frequent exacerbation (≥ 2 exacerbations per 
year), abnormal BMI (BMI < 21 or > 30  kg/m2), severe 
fatigue (CIS score ≥ 36 points), poor exercise capacity 
(6MWD < 70% predicted) and low daily physical activity 
(< 5000 steps per day) [18–24].
Statistical analysis
Continues variables when normally distributed were 
reported using means and 95% confidence interval (CI), 
and when not normally distributed as medians with 
interquartile ranges. Normality was assessed using Sha-
piro-Wilks test, and visually assessed using histogram 
and Q-Q plot. Categorical variables were reported using 
counts and percentages. The distribution of treatable 
traits between workforce connection groups was shown 
using a bar chart.
Between group comparison in baseline data was done 
using an independent T-test for continuous data if nor-
mally distributed, and Wilcoxon signed rank test if not 
normally distributed. For categorical data with two 
groups chi-square test was used and for multiple groups 
ANOVA was used.
Primary outcome was examined using a between group 
comparison of workforce connection groups (paid work 
vs. not paid work) and treatable traits using binomial 
logistic regression, reporting odds ratios (OR) and 95% 
confidence intervals (CI). Age, sex, forced expiratory vol-
ume in 1  s  (FEV1% predicted) and education level were 
examined together and included in the analysis of indi-
vidual treatable trait to adjust for relevant confounders 
[13, 14, 25, 26]. Patients with missing data in individ-
ual treatable traits were excluded from the individual 
analysis. A multiple logistic regression model including 
all treatable traits with a p-value below 0.2 in univari-
ate analyses was made to explore the importance of the 
individual treatable traits in relation to each other. Con-
tinuous variables were for the purpose of analysis with 
logistic regression checked for the linearity assumption 
by plotting the values against the corresponding logit of 
the model and if they were not linear then changed to 
relevant categories. Variables were checked for multicol-
linearity. Logistic regression models were checked for 
influential outliers defined as a Cook’s distance above 0.5 
or a standardized residual larger than three. There were 
no influential outliers.
Analysis was reported using R version 1.3.1093. A 
p-value and confidence interval (CI) was performed for 




The original database included 847 patients of which 
404 (48%) patients were included in the current study 
(see Fig. 1). The median age in the study population was 
58 (IQR 53–61) years, 60.6% had a low education level, 
and an average  FEV1% of 56% predicted, correspond-
ing to moderate airflow obstruction according to the 
Global initiative for Chronic Obstructive Pulmonary Dis-
ease (GOLD) classification [24]. A total of 191 (47%) of 
patients included did not have paid work (see Table 1).
Treatable traits and employment status
Differences are seen in all treatable traits’ variables favor-
ing patients who are part of the workforce as show in 
Table 1. Crude unadjusted OR are shown in the appen-
dix for all variables (Additional file 1: Fig. S1). Binomial 
logistic regression analysis including age, sex,  FEV1%, and 
education level revealed significant differences with age, 
and high education level of not being in paid work and 
with  FEV1% predicted increase favoring paid work (see 
Fig. 2). Analysis of individual treatable traits adjusted for 
age, sex,  FEV1, and education level revealed significant 
differences with daily activity, dyspnea, fatigue, exercise 
capacity, and exacerbations in the last year of not being 
in paid work (see Fig.  2). Missing data was present in 
MRC (N = 31), CIS (N = 96), and exacerbation frequency 
(N = 58) as shown in Fig. 2.
In the complete model including all treatable traits and 
confounders, only age and six-minute walk test remained 
significant. This analysis included 254 patients due to 




In this cross-sectional study of first time referred patients 
with COPD, below the age of 65, we found approximately 
half of the patients were not working. Low exercise 
capacity was the treatable trait that had the highest cor-
relation with not being in paid work as the only treatable 
trait that remained significant in the fully adjusted model 
(Fig.  2, Blue model). Low daily activity, higher dyspnea 
score, higher fatigue score, and two or more exacerba-
tions were however also significantly associated when 
adjusting for only age, sex,  FEV1% and education level 
(Fig. 2, Red model).
Page 4 of 8Jacobsen et al. Respir Res          (2021) 22:147 
Table 1 Demographics of population on workforce connection
Variable Level Total (n = 404) Paid work (n = 213) No paid work (n = 191) p-value
Age (years) Median [iqr] 58 [53, 61] 57 [52, 60] 58 [54.5, 62.0]  < 0.01
Age group  < 50 years 46 (11.4) 32 (15.0) 14 (7.3)
50–54 years 76 (18.8) 42 (19.7) 34 (17.8)
55–59 years 138 (34.2) 70 (32.9) 68 (35.6) 0.072
60–64 years 144 (35.6) 69 (32.4) 75 (39.3)
Sex Female 211 (52.2) 103 (48.4) 108 (56.5) 0.122
Educational level Low 245 (60.6) 118 (55.4) 127 (66.5)
Medium /High 159 (39.4) 95 (44.6) 64 (33.5) 0.039
Smoking status Never smoker 9 (2.2) 6 (2.8) 3 (1.6)
Active smoker 214 (53.0) 104 (48.8) 110 (57.6)
Previous smoker 181 (44.8) 103 (48.4) 78 (40.8) 0.180
Smoking history (years)π Median [iqr] 40 [30, 43] 38 [30, 40] 40 [32, 45] 0.085
FEV1% predicted Mean (sd) 55.9 (18.8) 58.5 (18.5) 52.9 (18.8)  < 0.01
FVC% predicted Mean (sd) 91.9 (17) 94.9 (17.2) 88.5 (16.2)  < 0.01
FEV1%/FVC% Mean (sd) 0.5 (0.1) 0.5 (0.1) 0.5 (0.1) 0.151
FEV1% predicted  < 30 46 (11.4) 28 (13.1) 18 (9.4)
30–59 190 (47.0) 113 (53.1) 77 (40.3)
50–79 143 (35.4) 63 (29.6) 80 (41.9)
 ≥ 80 25 (6.2) 9 (4.2) 16 (8.4)  < 0.01
Height Mean (sd) 170.1 (9.1) 171.4 (8.8) 168.7 (9.1)  < 0.01
Weight Median [iqr] 71 [60, 85] 71 [61, 85] 71 [59, 86] 0.475
BMI (kg/m2) Median [iqr] 24.8 [21.5, 28.6] 24.4 [21.8, 27.8] 25.3 [21.1, 29.0] 0.579
BMI  < 21 kg/m2 88 (21.8) 40 (18.8) 48 (25.1)
21–30 kg/m2 242 (59.9) 137 (64.3) 105 (55.0)
 > 30 kg/m2 74 (18.3) 36 (16.9) 38 (19.9) 0.148
Abnormal BMI  < 21 or > 30 kg/m2 162 (40.1) 76 (35.7) 86 (45.0) 0.070
Exacerbations previous  year€ 0–1 Exacerbations 243 (70.2) 145 (76.3) 98 (62.8)
 ≥ 2 Exacerbation 103 (29.8) 45 (23.7) 58 (37.2)  < 0.01
Steps per day  < 5000 151 (37.4) 57 (26.8) 94 (49.2)  < 0.01
6MWD predicted  < 70% 203 (50.2) 83 (39.0) 120 (62.8)  < 0.01
MRCα 1 99 (26.5) 59 (29.8) 40 (22.9)
2 116 (31.1) 72 (36.4) 44 (25.1)
3 92 (24.7) 42 (21.2) 50 (28.6)
4 42 (11.3) 17 (8.6) 25 (14.3)
5 24 (6.4) 8 (4.0) 16 (9.1)  < 0.01
MRCα  ≥ 3 158 (42.4) 67 (33.8) 91 (52.0)  < 0.01
CIS  pointsΩ Mean (sd) 37.3 (12.5) 36.2 (12.3) 38.7 (12.7) 0.080
CISΩ  ≥ 36 points 180 (58.4) 86 (52.8) 94 (64.8) 0.042
Comorbidities
 Arterial  hypertension# 30 (23.3) 14 (21.5) 16 (25.0) 0.797
 Coronary artery  disease# 9 (7.0) 4 (6.2) 5 (7.8) 0.981
 Heart  attack# 8 (6.2) 4 (6.2) 4 (6.2) 1.000
 Heart rhythm  disturbance# 4 (3.1) 2 (3.1) 2 (3.1) 1.000
 Cerebral  infarction# 6 (4.7) 2 (3.1) 4 (6.2) 0.662
 Chronic heart  failure# 4 (3.1) 2 (3.1) 2 (3.1) 1.000
 Peripheral vascular  disease# 7 (5.4) 3 (4.6) 4 (6.2) 0.983
  Anemia# 1 (0.8) 0 (0.0) 1 (1.6) 0.994
  Diabetes# 9 (7.0) 5 (7.7) 4 (6.2) 1.000
 Chronic renal  failure# 3 (2.3) 1 (1.5) 2 (3.1) 0.989
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Workforce connection
The percentage of patients outside the workforce in this 
population (47.3%) is lower than in studies from England 
(59%) and Denmark (60%) [4, 5]. A reason for this may 
be that the current study consists of patients referred for 
the first time to an outpatient respiratory clinic and may 
therefore exclude patients with more progressive disease 
who will be more likely to be already on permanent sick 
leave. An indication of this is seen in the study from UK 
where 47.2% of patients were in the high age group (60–
64) years compared to 35.6% in this study. The lower age 
in this study may indicate a less vulnerable group which 
could explain the differences seen in paid work.
Treatable traits and employment status
The hypothesis that COPD patients without paid work 
are more vulnerable regarding the prevalence of treatable 
traits is accepted in this study, with a higher prevalence 
of all treatable traits in patients without paid work. The 
causal effects of this relationship are, however, uncertain 
due to the observational nature of the study. It may be 
that patients outside the workforce have more treatable 
traits because they do not have a work life. For example, 
not being in paid work may enforce a more sedentary life-
style which leads to a deteriorating health status. It may 
also be that patients outside the workforce have left the 
workforce due to an increasing burden of COPD, includ-
ing lower exercise capacity and daily activity and thereby 
lost the ability to work. Prospective cohort studies of 
patients with COPD part of the workforce are needed to 
explore the causal effects of the associations seen in this 
study.
The treatable trait most strongly correlated to being 
outside the workforce is decreased exercise capacity. This 
variable is the only treatable trait that remains significant 
(95% CI) in the analysis with all treatable traits and con-
founders included in the same model (Fig. 2. Blue model). 
This is consistent with findings in people outside the 
work force in general and therefore important to incor-
porate in attempts to improve patients workforce con-
nection [27].
Possible interventions
Different evidence-based interventions exist for patients 
with COPD such as pulmonary rehabilitation, smoking 
cessation, and nutritional advice which aim at prevent-
ing decline in function and improve physical activity, 
exercise capacity and quality of life (QoL) [19, 21, 22, 28]. 
Whether pulmonary rehabilitation which may improve 
all the significant treatable traits, will lead to patients 
returning to work is unknown due to the unknown causal 
effects of the treatable traits examined [19, 29].
Cross sectional studies have suggested that smok-
ing cessation may improve workforce connection in the 
COPD population [14, 30]. Smoking status does not 
reveal significant differences with paid work in our study. 
This might be while successful smoking cessation may be 
preceded by a larger burden of tobacco related diseases 
as a previous study has suggested. Some patients who 
managed to quit may therefore have higher morbidity 
than the current smoker and thereby diminish the effect 
seen in the smoking cessation variable [31].
The finding that patients with higher exacerbation 
frequency are more likely to be outside the work-
force (Fig.  2, Red model), may be related to medicine 
Table 1 (continued)
Variable Level Total (n = 404) Paid work (n = 213) No paid work (n = 191) p-value
  Osteoporosis# 8 (6.2) 5 (7.7) 3 (4.7) 0.732
 Skeletal muscle dysfunction / 
muscle  weakness#
1 (0.8) 0 (0.0) 1 (1.6) 0.994
  Arthrosis# 13 (10.1) 5 (7.7) 8 (12.5) 0.539
  Depression# 13 (10.1) 4 (6.2) 9 (14.1) 0.230
  Anxiety# 7 (5.4) 3 (4.6) 4 (6.2) 0.983
 Cognitive  impairment# 1 (0.8) 1 (1.5) 0 (0.0) 1.000
 Gastroesophageal  reflux# 6 (4.7) 2 (3.1) 4 (6.2) 0.662
 Obstructive sleep  apnea# 2 (1.6) 2 (3.1) 0 (0.0) 0.483
  Cancer# 4 (3.1) 0 (0.0) 4 (6.2) 0.124
Comorbidity  count# 0 29 (22.5) 20 (30.8) 9 (14.1)
1 48 (37.2) 20 (30.8) 28 (43.8)
2 + 52 (40.3) 25 (38.5) 27 (42.2) 0.062
Forced vital capacity (FVC), Forced expiratory volume in one second  (FEV1), Standard deviation (sd), Interquartile range (IQR), Body mass index (BMI), Medical research 
council dyspnea score (MRC)
Missing data: πn = 108, $n = 95, §n = 97, &n = 107, €n = 58, αn = 31, Ωn = 96, Ⅎn = 17, ∂n = 23, #n = 275
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adherence. Previous studies have found that unem-
ployed patients have poorer medical adherence than 
patients’ part of the workforce [7]. If medical adherence 
would have effects on workforce connection is specu-
lative. The negative effects of exacerbation on disease 
progression however stresses the need for adherence in 
patients in and especially outside the workforce [32].
This study suggests potential areas of intervention 
aimed at improving workforce connection. Patients’ 
part of the workforce could benefit from the interven-
tions by improving and maintaining function hereby 
preventing workforce detachment. For patients outside 
the workforce, interventions may help reestablish the 
workforce connection and improve their general health 
and QoL. Prospective interventional studies specifically 
aimed at improving COPD patients’ workforce connec-
tion are however lacking and are much needed [33, 34].
Comorbidities were not examined using logistic 
regression due to much missing data. ANOVA how-
ever revealed a tendency towards more comorbidities 
in patients without paid work (P = 0.06 (see Table  1)). 
This indicates that patients outside the workforce may 
be more vulnerable with multiple diseases interact-
ing rather than their COPD diagnosis by itself. A rela-
tively high unemployment rate is observed in patients 
with COPD when compared to other chronic diseases 
[4]. This makes the attention to patients with COPD 
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1 2 3 4
Fig. 2 Logistic regression model exploring treatable traits related with not being in paid work. Red model: *OR of model including only 
confounders. Missing data for specific treatable traits are shown in Na column. †OR of treatable traits adjusted for age, sex,  FEV1% and educational 
level. Blue model: Including all confounders * and treatable traits † in the same model. Due to missing data across different treatable traits 150 
patients were excluded from blue analysis leaving 254 with complete data. Odds Ratio (OR), Confidence Interval (CI), standard deviation (sd), 
Interquartile range (IQR), Forced Expiratory Volume in one second  (FEV1), Medical Research Council (MRC score), Body Mass Index (BMI), Checklist 
Individual Strength (CIS), 6 min walk distance (6MWD).
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Limitations
The study has some limitations. First, the prevalence 
of patients outside the workforce may be different than 
among other populations because this study only included 
patients referred for the first time to a secondary clinic. 
The study is however ideal for evaluating COPD patients’ 
treatable traits while patients have their first contact with 
the secondary healthcare system regarding their COPD. 
Second, knowledge on previous work experience and why 
patients were not in paid work was not available. It may be 
that more physical demanding work would be more prev-
alent among those who have left the workforce. Education 
level may play a role in this effect but without the data the 
question remains unanswered in this study. Information 
on why patients left the workforce may also have con-
firmed that more females leave the workforce by choice. 
Third, due to missing data across different variables, the 
number of patients who could contribute to the analy-
sis of all treatable traits dropped with almost 40% which 
may also explain why the previously significant variables 
became non-significant in the full model adjusting for 
all covariates and traits. The fraction of missing data was 
evenly distributed across the study sites and we did not 
have reason to believe that there were systematic record-
ing errors that would bias the findings.
Fourth, pack years may have contributed to the 
understanding of smoking’s effect on paid work. This 
was unfortunately not available.
Fifth, we unfortunately did not have access to adher-
ence data as a treatable trait. This information could 
have improved the understanding of treatable traits and 
may have helped explain the increased exacerbation 
frequency seen in patients without paid work.
Conclusion
Patients with COPD who are not employed have an 
increased number of treatable traits with exercise 
capacity being the most important predictor. Interven-
tional studies using for example pulmonary rehabilita-
tion and exercise training addressing individual patient 
goals related to reestablishing or maintaining workforce 
connection are needed to explore if workforce connec-
tion may be improved.
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